TransMedics Group, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 20, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX) for violations of the securities laws. The investigation focuses on whether the Company issued false […]

Investors With Losses Are Invited To Join The Schall Law Firm In An Inquiry Into Singular Genomics Systems, Inc. For Securities Fraud

LOS ANGELES, CA / ACCESS Newswire / January 20, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Singular Genomics Systems, Inc. ("Singular Genomics" or "the Company") (NASDAQ:OMIC) for potential breaches of fiduciary duty on the part of its directors and

Polestar Automotive Holding UK PLC Investigated Regarding Potential Securities Law Violations – Contact Levi & Korsinsky for Details – PSNY

NEW YORK, NY / ACCESS Newswire / January 20, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Polestar Automotive Holding UK PLC ("Polestar Automotive Holding UK PLC") (NASDAQ:PSNY) concerning possible violations of federal securities laws. On January 16, 2025, Polestar filed a report with the U.S. Securities and Exchange

NTLA ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Intellia Therapeutics, Inc. investment

NEW YORK, NY / ACCESS Newswire / January 20, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Intellia Therapeutics, Inc. ("Intellia Therapeutics, Inc.") (NASDAQ:NTLA) concerning possible violations of federal securities laws. Intellia issued a press release on January 9, 2025, "announc[ing] its strategic priorities and key anticipated 2025 milestones".

Neumora Therapeutics, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations – NMRA

NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Neumora Therapeutics, Inc. ("Neumora Therapeutics, Inc.") (NASDAQ:NMRA) concerning possible violations of federal securities laws. On January 2, 2025, Neumora announced its experimental depression treatment failed in the first of three studies

Class Action Filed Against Transocean Ltd. (RIG) – February 24, 2025 Deadline to Join – Contact Levi & Korsinsky

NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=123910&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Revance Therapeutics, Inc. (RVNC) Shareholders

NEW YORK, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Revance Therapeutics, Inc. (NASDAQ:RVNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/revance-therapeutics-inc-lawsuit-submission-form?prid=123904&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Did Newmont Corporation Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate – NEM

NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Newmont Corporation ("Newmont Corporation") (NYSE:NEM) concerning possible violations of federal securities laws. On October 23, 2024, Newmont reported 3Q 2024 earnings that fell below expectations, as well as rising operational costs.

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Treace Medical Concepts, Inc. For Securities Law Violations

LOS ANGELES, CA / ACCESS Newswire / January 20, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation focuses on whether the Company issued

Levi & Korsinsky Notifies Shareholders of Marqeta, Inc. (MQ) of a Class Action Lawsuit and an Upcoming Deadline

NEW YORK, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Marqeta, Inc. (NASDAQ:MQ) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/marqeta-inc-lawsuit-submission-form?prid=123913&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Scroll to Top